Latest News & Features
Asia-Pacific
Gilead has been granted a patent for its hepatitis C drug Sovaldi in India, despite concerns over the cost of the drug. 10 May 2016
Americas
Pharmaceutical company Sanofi has failed to transfer the domain name sanofi.xin, despite the fact it has a registered trademark for exactly the same term. 9 May 2016
Americas
The US Federal Trade Commission has approved a final order settling charges that pharmaceutical company Hikma’s buyout of Roxane Laboratories and Boehringer Ingelheim Roxane would be anticompetitive. 6 May 2016
Americas
AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business. 5 May 2016
Americas
Pharmaceutical company Allergan has received approval from the US Food and Drug Administration to launch a generic version of a cholesterol drug owned by AstraZeneca. 5 May 2016
Americas
CRISPR is only part of the gene editing story, and by studying the patents associated with all of the various methods, a much clearer picture of the entire field can be generated, says Tony Trippe, senior patent analyst for Thomson Reuters. 5 May 2016
Big Pharma
Law firm Cooley has hired Colm Murphy as a partner in the firm’s life sciences patent counselling and prosecution practice in London. 4 May 2016
Asia-Pacific
Australia’s patent system is “poorly targeted” and protection for pharmaceutical inventions is “excessive”, according to a government advisory committee. 4 May 2016
Americas
A judge assessing a patent dispute between Merck and Gilead centring on hepatitis C treatments has allowed Gilead to submit new evidence of jurors allegedly being misled. 3 May 2016
Africa
The Biotechnology Innovation Organization has welcomed the US Trade Representative’s “Special 301 Report”, which it said “aims to advance global IP rights in biotechnology in a number of constructive ways”. 29 April 2016